Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Tissue Antigens|June 18, 1999
Correction of HLA-Cw*0501 and identification of HLA-Cw*0711J F Baurain, P G CoulieFacts, Views & Vision in Obgyn|December 23, 2016
New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genesI Vergote, V Bours, B Blaumeiser, et al.Acta Clinica Belgica|January 22, 2016
Unusual pulmonary toxicity of ipilimumab treated by macrolidesM Mailleux, F Cornélis, G C Colin, et al.Advances in Cancer Research|April 28, 1999
Antitumor immunity at work in a melanoma patientP G Coulie, H Ikeda, J F Baurain, et al.Acta Clinica Belgica|April 14, 2011
Epidermal growth factor receptor targeted therapies for solid tumoursM Van den Eynde, J F Baurain, F Mazzeo, et al.Acta Gastro-Enterologica Belgica|October 23, 2020
Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patientJ Vandepapelière, J Siplet, L Libbrecht, et al.Cancer Research|December 3, 1999
Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping geneR Chiari, F Foury, E De Plaen, et al.Acta Clinica Belgica|February 18, 2012
New drugs in medical oncology: new difficulties to distinguish drug-induced side effects from cancer complications: a case-reportE Seront, F Mazzeo, M Mano, et al.Cancer Research|May 19, 2001
A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinomaH Echchakir, F Mami-Chouaib, I Vergnon, et al.Acta Gastro-Enterologica Belgica|July 10, 2023
Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patientN Baczewska, M Philippart, J Siplet, et al.Pageof 3